TherapeuticsMD (TXMD)
TherapeuticsMD (TXMD) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.
- TXMD last traded at $1.81 on 2026-11-19, 0.00% for the session.
- TherapeuticsMD: market cap $20.95M, P/E 171.7, revenue $3.75M over the last four quarters.
- Over the past year TXMD returned 9.70%, with a year-to-date return of 11.04%.